Spectroscopy Feeds

Spectroscopy General

Abbott's Tacrolimus assay provides consistent medication monitoring for organ transplant patients

A new study published in the journal Clinical Chemistry reported Abbott's ARCHITECT Tacrolimus assay provides accurate and consistent medication monitoring for patients taking tacrolimus, an immunosuppressive medication, after receiving solid organ transplantation.
 

UofL to receive Grand Challenges tuberculosis biomarkers grant

The University of Louisville announced today that it will receive a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. James E. Graham, Ph.D., associate professor of microbiology and immunology at the UofL School of Medicine, will pursue an innovative research project to identify and validate TB biomarkers, titled "Disposable Sampling Plate and Breath Test to Identify Patients with Active Tuberculosis."
  

SERS may benefit from new, single-step method of fabricating microcapsules

A new, single-step method of fabricating microcapsules, which have potential commercial applications as a substrate for surface-enhanced Raman spectroscopy (SERS), and in industries including medicine, agriculture and diagnostics, has been developed by researchers at the University of Cambridge, UK. Their have been published in Science titled “One-Step Fabrication of Supramolecular Microcapsules from Microfluidic Droplets”.

 

Researchers discover new biomarker for cyanide poisoning

Researchers have found a new biomarker for cyanide poisoning, which may extend its detection window in death investigations by weeks if not months.
  

Thermo Fisher fourth quarter revenues increase 15% to $3.13B

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2011.
 

HSP40/70 linked to hepatitis C infection

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.
  

Page 1 of 3

Products Updates

  • 1
  • 2
  • 3
  • 4

Microscopy Headlines

  • 1
  • 2
  • 3
  • 4

Spectroscopy Headlines

  • 1
  • 2
  • 3
  • 4